Portfolio company
SEncIL
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
SEncIL develops encapsulation technology that transforms liquid drugs into polymer-encapsulated powders to improve oral drug delivery for pharmaceutical companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Biograil
This biotech company develops a capsule device that enables oral delivery of injectable biologic drugs for pharmaceutical firms and patients.
Exolvo Biosciences
Exolvo Biosciences develops oral smart capsules for the delivery of biologic drugs to pharmaceutical companies and patients.
Exolvo
This company develops smart capsules using dissolvable microneedles for the oral delivery of biologic drugs to pharmaceutical partners and patients.
InkVivo
The company develops polymer-based drug delivery systems for pharmaceutical and nutraceutical industries to enhance therapeutic adherence and efficacy.
Ensilitech
This company develops silica-based encapsulation technology to stabilise vaccines and biopharmaceuticals without refrigeration for biotechnology and pharmaceutical companies.
Nexos
Nexos Biosciences develops exosome-based drug delivery systems for pharmaceutical companies to enable oral administration of treatments for cancer, inflammation, and metabolic diseases.
IamFluidics
IamFluidics produces microencapsulation solutions for pharmaceutical, life science and personal care customers to enable controlled release of ingredients and culturing of live cells.
Drug Delivery
This company develops ingestible technology for drug delivery and health monitoring to serve patients and healthcare providers.
